Premium
Arsenene Nanodots with Selective Killing Effects and their Low‐Dose Combination with ß‐Elemene for Cancer Therapy (Adv. Mater. 37/2021)
Author(s) -
Liu Chuang,
Sun Shan,
Feng Qiang,
Wu Gongwei,
Wu Yiting,
Kong Na,
Yu Zhangsen,
Yao Junlie,
Zhang Xingcai,
Chen Wei,
Tang Zhongmin,
Xiao Yufen,
Huang Xiangang,
Lv Aman,
Yao Chenyang,
Cheng Haibo,
Wu Aiguo,
Xie Tian,
Tao Wei
Publication year - 2021
Publication title -
advanced materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.707
H-Index - 527
eISSN - 1521-4095
pISSN - 0935-9648
DOI - 10.1002/adma.202170292
Subject(s) - nanodot , materials science , nanotechnology , drug , peg ratio , pharmacology , medicine , finance , economics
Arsenical Drugs In article number 2102054, Aiguo Wu, Tian Xie, Wei Tao, and co‐workers reveal PEGylated arsenene nanodots (AsNDs@PEG) with high monoelemental arsenic purity and negligible systemic toxicity as a new‐concept arsenical drug. This AsNDs@PEG, when applied in a low‐dose combination strategy with β‐elemene, a plant‐derived anticancer drug, achieves synergistic therapeutic outcomes.